| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $769.3M | +11.6% |
| Cost of Revenue | $174.1M | +2.1% |
| Gross Profit | $595.2M | +14.8% |
| R&D Expense | $209.3M | +18.0% |
| SG&A Expense | $128.8M | +8.3% |
| Operating Income | $65.2M | +679.1% |
| Pre-tax Income | $90.4M | +85.0% |
| Income Tax | -$125.2M | -6389.4% |
| Net Income | $215.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $305.8M | +283.9% |
| Short-term Investments | $316.3M | -32.8% |
| Accounts Receivable | $75.5M | -26.8% |
| Current Assets | $911.1M | +3.1% |
| Total Assets | $1.21B | +16.8% |
| Current Liabilities | $268.4M | -8.4% |
| Long-term Debt | $357.9M | +0.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $153.6M | +464.1% |
| Capital Expenditures | $3.5M | +409.8% |
| Investing Cash Flow | $137.6M | +55.8% |
| Financing Cash Flow | -$82.0M | +28.3% |
| Free Cash Flow | $150.0M | +465.6% |
| +359.8% |
| EPS (Basic) | $1.61 | +360.0% |
| EPS (Diluted) | $1.52 | +2433.3% |
| Total Liabilities |
| $636.2M |
| -3.1% |
| Stockholders' Equity | $575.4M | +51.0% |